Hi there! I'm an inclusive leader who builds trust, teams, and products.



The role of a designer is that of a very good, thoughtful host anticipating the needs of his guests.

- Charles Eames



VP, Platform Product Management
Change Healthcare
May 2018 - Present

VP of Product
October 2017 - May 2018

Director, Platform Product Management
Change Healthcare
June 2014 - October 2017

Manager, Operations
Oracle Corporation
October 2010 - May 2014

Founder & Managing Partner
Divvy Dot Consulting Group
May 2010 - December 2015

Business Analyst
Phase Forward
November 2009 - October 2010

Performance Coach
Clarix, LLC
April 2009 - November 2009

Product Manager
Clarix, LLC
May 2008 - April 2009

April 2007 - May 2008

Director, Clinical Research & Quality Improvement
The Wound Clinic
July 2005 - May 2006



Dartmouth College | Hanover, NH

September 2001 - June 2005

Bachelor of Arts. High Honors.
Major: English Literature. Senior Fellow.

Universidad Popular Autonoma del Estado de Puebla | Puebla, Mexico

January 2003 - April 2003

Language Study Abroad.

Stanford Graduate School of Business | Palo Alto, CA

March 2017 - April 2017 Design Thinking Executive Bootcamp: From Insights to Innovation

Bryn Mawr College | Bryn Mawr, PA

May 2006 - May 2007

Certificate. Postbaccalaureate Premedical Program.



Certified Scrum Product Owner
Scrum Alliance     
April 2016

Certified Agile Leadership
Scrum Alliance
December 2018

Certified SAFe 4 PO/PM
Scaled Agile, Inc.      
December 2018

Real Estate License #009527943
Commonwealth of Massachusetts
July 2013

Certified SAFe 4 Agilist
Scaled Agile, Inc.    
November 2018

Certified SAFe 4 Scrum Master
Scaled Agile, Inc.
November 2018



Kelsey is always willing to go the extra mile to ensure a team’s success and is an incredible addition to any organization. Her passion for working through problems that benefit the customer is unmatched. I truly miss working on Kelsey’s organized, dedicated, and committed team.
— Jordan Ferris, Grants & Contracts Administrator @ Duke University School of Medicine
Kelsey is one of the most influential leaders I’ve had the privilege of meeting in my career. She constantly seeks to learn, making her an invaluable resource to any team. She is both a manager and a mentor, a true people developer. I look forward to the day that I have the opportunity to work for her again!
— Jacqueline Dunn, Product Manager - Artificial Intelligence @ Change Healthcare
Kelsey leads with such fury and passion for a project, that it seems as if no stone is left unturned. This is something I strive to do myself, and have definitely gained perspective.
— Asmir Hajric, Engineer @ AT&T
Kelsey is a demonstrated high-performer who consistently produces results above and beyond expectations. She is one of the most proactive individuals I have worked with, never being held back by lack of training, detailed instructions, or specific guidance. Her sense of personal accountability and responsibility to her colleagues and clients is unparalleled. Kelsey’s work product is always of the highest quality and reflects her creativity and attention to detail. Kelsey can produce not only quality work, but quantity as well. I could rely on her to complete projects in record time, thanks not only to her great work ethic, but also to her talent for organization and efficiency. Kelsey works hard, but she also works smart. She is highly intelligent, curious, and a skillful autodidact (self-directed learner) with a hunger for knowledge. Any employer would be fortunate to work with someone of Kelsey’s caliber.
— Amity Cox Swain, CoFounder @ Sydespace



Chronic Wounds of the Lower Extremity: A Preliminary Performance Measurement Set

Harlin SL, Willard LA, Rush KJ, Ghisletta LC, Meyers WC

January 2008

Journal of Plastic & Reconstructive Surgery


Narrative Writing Therapy: A Physician's Tool for Understanding the Adolescent Illness Experience

Rush KJ

May 2005

Dartmouth College


Products in the Press

Amazon Web Services Now Hosting Change Healthcare’s Blockchain Tech in the Cloud

Change Healthcare on Tuesday said that its blockchain-enabled Intelligent Healthcare Network will be available on Amazon Web Services.

Change’s network enables blockchain technologies for more secure and efficient financial transactions throughout the claims process.

Hospitals and health insurance companies can use the cloud service to track the status of claims submissions and remittances. They will benefit from having an immutable, auditable and accessible record, as well as reduced administrative costs and near real-time claim adjudication, Change said.



Calculating Odds for a Successful In Vitro Fertilization

Nearly 12 percent of women between the ages of 15 and 44 have difficulty conceiving and turn to fertility services, according to the Centers for Disease Control and Prevention. But those services can be very expensive: A cycle of IVF, or in vitro fertilization, costs an average of $23,000, according to FertilityIQ.

Enter Univfy, a company founded by Dr. Mylene Yao, an obstetrician-gynecologist who has developed models to better predict a woman's likelihood of conceiving using IVF. Yao likens it to a "FICO score for fertility" -- a way of assessing a patient's risk factors and determining her chances of having a baby. (FICO scores are assessments of consumer credit used to determine eligibility for loans, among other financial services.)



Aetna, Change Healthcare Partner on Aetna Pay to Collect Patient Payments Faster

Aetna and Change Healthcare are collaborating on a bill paying system that is helping providers collect money for the revenue cycle operation faster by making it easier for patients to understand the charges. 

Aetna Pay, which runs on a Change Healthcare chassis, wades through the "consumer morass" for patients trying to understand their bill, said Erin Hatzikostas, president of PayFlex for Aetna.



Oracle Acquires Phase Forward for $17.00/share

Oracle announced that it has agreed to acquire Phase Forward (NASDAQ: PFWD), a leading provider of applications for life sciences companies and healthcare providers, through a cash merger for $17.00 per share, or approximately $685 million.

Phase Forward’s SaaS-based Integrated Clinical Research Suite manages clinical development and safety processes from Phase 1 clinical trials through regulatory submission and post-approval monitoring. Adding complementary assets to Oracle Health Sciences, the combination is expected to enable researchers, clinical development professionals, physicians, regulators and patients to more effectively and securely capture, contribute, access and share data. The acquisition of Phase Forward is consistent with Oracle’s strategy to provide mission-critical applications for key industries.



Phase Forward Buys Clarix for $40M

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has acquired privately held Clarix LLC, an innovative provider of fully Web-integrated interactive response technology (IRT), for $40 million in cash. Clarix, headquartered in Radnor, PA, will continue to operate from its existing offices as part of Phase Forward. 

Clarix’s fully Web-integrated IRT is used for subject randomization, predictive medication inventory management, and operational management and reporting in clinical trials. Clarix combines a next-generation technology platform with a services organization focused on delivering the highest levels of customer satisfaction to enable customers to set up trials in less than half the time it typically takes with traditional IRT providers.




The Chestnut Hill Local, a neighborhood newspaper, stopped by phillydogspot to learn more about the do it yourself dog wash.



Name *